Close Menu
    Latest Category
    • Finance
    • Tech
    • EU Law
    • Energy
    • About
    • Contact
    EUbusiness.com | EU news, business and politicsEUbusiness.com | EU news, business and politics
    Login
    • EU News
    • Focus
    • Guides
    • Press
    • Jobs
    • Events
    • Directory
    EUbusiness.com | EU news, business and politicsEUbusiness.com | EU news, business and politics
    Home » Brussels cuts red tape in health sector to speed up innovation

    Brussels cuts red tape in health sector to speed up innovation

    eub2eub216 December 2025Updated:17 December 2025 Health
    — Filed under: EU News
    Share
    Facebook Twitter LinkedIn Pinterest Email

    The EU Commission continues efforts to cut red tape in the single market with a package of measures which it says will improve Europeans’ health while ensuring long-term resilience and competitiveness in the health sector.

    Oliver Varhelyi - Valdis Dombrovskis - Photo © European Union 2025

    The package includes a Biotech Act, revised rules for medical devices, and a Safe Hearts Plan, which will:

    • strengthen the EU biotechnology sector;
    • accelerate the development of innovative new treatments and therapies for patients;
    • make rules for the development of medical devices from lab to market simpler and more efficient for EU companies, while ensuring a very high level of patient safety;
    • tackle Europe’s leading cause of death, cardiovascular diseases, with a comprehensive EU approach to prevent, detect, and treat them in time.

    “When innovation happens in Europe new treatments reach European patients faster and at an affordable cost, which is essential for robust world-class care,” said the EU Health Commissioner Olivér Várhely: “This is why today we are unlocking a new era of growth in the health sector with the Biotech Act, making Europe a global hub for health biotechnology. We are making it easier and faster to get life-saving medical devices to patients, and tackling Europe’s biggest killer – cardiovascular disease – with our ambitious Safe Hearts Plan.”

    The Commission says the proposed Biotech Act will incentivise companies to conduct research and production within Europe, accelerate clinical trials authorisations across countries, and fast-track the development of cutting-edge new therapies using AI, data and regulatory sandboxes. It will also simplify EU regulations to reduce costs and burdens for companies. For complex innovative products it will establish single regulatory pathways.

    Cardiovascular diseases kill 1.7 million Europeans every year, and cost the European economy €282 billion annually, says the Commission. The Safe Hearts Plan will help individuals with personalised disease prediction tools and therapies, while addressing risk factors like tobacco, unhealthy diets, and alcohol. It seeks to bridge research gaps and integrate data, digital solutions and artificial intelligence to strengthen health systems. With levels of early cardiovascular deaths varying significantly across EU countries, the Plan emphasises reducing health inequalities and improving access to healthcare and therapies. For example, the Commission will support Member States in developing national cardiovascular health plans, establish dashboards monitoring health inequalities, and launch an Incubator to speed up the use of AI.

    The medical devices sector employs close to one million people, mostly in small and medium-sized enterprises, and the EU market is worth around €170 billion. The new proposals will simplify EU rules for medical devices, support the digitalisation of procedures, and offer a coherent framework so that companies can respond to changing market conditions and patient needs. To speed up access to medical devices and guarantee a continuous supply, timelines to complete conformity assessments will be introduced.

    A stronger role for the European Medicines Agency (EMA) will strengthen coordination at EU level while companies will be offered more scientific, technical and regulatory expertise. The EMA will also monitor shortages of medical devices, and a list of critical devices will be created. Finally, the proposal will ensure uniform and coherent rules for medical devices incorporating AI applications. Altogether, the measures should lead to overall cost savings of €3.3 billion per year, says the Commission, including €2.4 billion annual administrative savings.

    Proposal for a Regulation to establish measures to strengthen the Union’s biotechnology and biomanufacturing sectors (European Biotech Act)

    Proposal for a Directive to place genetically modified micro-organisms and the processing of organs on the market

    Communication on an EU cardiovascular health plan: the Safe Hearts Plan

    Proposal for a regulation to simplify rules on medical and in vitro diagnostic devices

    Questions and answers: Biotech Act 

    Questions and answers: Safe Hearts Plan 

    Questions and answers: Medical Devices 

    Add A Comment
    Leave A Reply Cancel Reply

    You must be logged in to post a comment.

    eub2
    • Website

    eub2 is the default publisher for EUbusiness.

    Related Content

    Running - Image by Th G from Pixabay

    EU sets out vision for sport in Europe

    AIM logo

    Project Manager, International Association of Mutual Benefit Societies, AIM

    ESIP - European Social Insurance Platform logo

    Policy Officer in Healthcare, European Social Insurance Platform, ESIP

    Access VetMed logo

    Public Affairs Advisor, Access VetMed

    Wine bottles - Photo by CHUTTERSNAP on Unsplash

    5 pct of Europeans consumed alcohol daily in 2025

    Health screening - Image © European Union 2026

    Brussels launches EU Screening Week

    LATEST EU NEWS
    Wrapping plastics packaging - Photo by Léster Lau on Pexels

    Rules prohibiting EU exports of plastic waste to non-OECD countries enter into force

    20 November 2026
    UK-EU-Ursula von der Leyen, Andy Burnham, António Costa - Photo © European Union 2026

    Brexit reset underway as UK’s deal with EU offers new opportunities for young people

    20 November 2026
    Oil tanker - Image by Erich Westendarp from Pixabay

    EU to delay methane reporting and monitoring for energy importers

    19 November 2026
    AI - Artificial Intelligence - Image by Gerd Altmann from Pixabay

    EU calls on states to equip citizens for the age of AI

    19 November 2026
    Euro - ECB-Photo by Mika Baumeister on Unsplash

    November currency outlook – Euro currency news

    19 November 2026

    Subscribe to EUbusiness Week

    Get the latest EU news

    CONTACT INFO

    • EUbusiness, 117 High Street, Chesham Buckinghamshire, HP5 1DE, United Kingdom
    • +44(0)20 8058 8232
    • service@eubusiness.com

    INFORMATION

    • About Us
    • Advertising
    • Contact Info

    Services

    • Cookie Policy
    • Terms
    • Disclaimer

    SOCIAL MEDIA

    Facebook
    eubusiness.com © EUbusiness Ltd 2026

    Type above and press Enter to search. Press Esc to cancel.

    Manage Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    • Manage options
    • Manage services
    • Manage {vendor_count} vendors
    • Read more about these purposes
    View preferences
    • {title}
    • {title}
    • {title}
    Manage Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    • Manage options
    • Manage services
    • Manage {vendor_count} vendors
    • Read more about these purposes
    View preferences
    • {title}
    • {title}
    • {title}

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?